Kango Sujay Insider Trades

Insider Trading History

Track insider trading activity for Kango Sujay. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $533k 6,090 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$546k 6,090 shares
$89.63
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $2.19M 25,000 shares
Last Trade
Mar 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$497k 25,000 shares
$19.86
$87.53
MEI Pharma
MEI Pharma MEIP
Director
Holding Value $30.7k 10,000 shares
Last Trade
Sep 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.1k 10,000 shares
$7.01
$3.07
MEI Pharma
MEI Pharma MEIP
Director
Holding Value $269k 87,500 shares
Last Trade
Jul 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9M 87,500 shares
$216.04
$3.07
Infinity Pharmaceuticals
Infinity Pharmaceuticals INFI
Director
Holding Value $720 90,000 shares
Last Trade
Mar 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102k 90,000 shares
$1.13
$0.01
MEI Pharma
MEI Pharma MEIP
Director
Holding Value $179k 58,334 shares
Last Trade
Nov 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.8M 58,334 shares
$1,076.00
$3.07
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$3.31M 18,509 shares
$178.75
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.74M 20,896 shares
$178.75
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $3.31M 18,509 shares
Last Trade
Sep 27, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$875k 5,000 shares
$175.00
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $4.2M 23,509 shares
Last Trade
Sep 27, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$894k 5,000 shares
$178.87
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $4.47M 25,000 shares
Last Trade
Sep 27, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$894k 5,000 shares
$178.87
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $3.31M 18,509 shares
Last Trade
Sep 21, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$750k 5,000 shares
$150.03
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $4.2M 23,509 shares
Last Trade
Sep 21, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$766k 5,000 shares
$153.29
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $5.36M 30,000 shares
Last Trade
Sep 21, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$766k 5,000 shares
$153.29
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $4.36M 24,396 shares
Last Trade
Mar 02, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$679k 5,000 shares
$135.85
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $6.26M 35,000 shares
Last Trade
Mar 02, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$679k 5,000 shares
$135.85
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $3.88M 21,697 shares
Last Trade
Mar 02, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$680k 5,000 shares
$136.01
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $3.31M 18,509 shares
Last Trade
Feb 12, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$116k 887 shares
$130.87
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $3.47M 19,396 shares
Last Trade
Jan 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.41M 20,896 shares
$115.53
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Chief Commercial Officer
Holding Value $2.5M 13,987 shares
Last Trade
Jan 04, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$169k 1,357 shares
$124.31
$178.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up